Skip to main content
OpenTrials
Completed

NCT Number: NCT02221817

Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis

Trochanteric bursitis is a common condition, effecting 20% of the population. \\Most with trochanteric bursitis experience chronic intermittent or continuous hip pain at and around the greater trochanter.

The cause of trochanteric bursitis is believed to be a result of inflammation of the bursa, though this has not been confirmed. Accordingly, the use of corticosteroid injections has been shown to provide considerable relief. However, routine "blind" injections, those performed without the aid of imaging, such as fluoroscopy, have shown limited success in the appropriate needle placement. Fortunately, blind injections have yielded positive results in majority of the cases. Additionally, the use of fluoroscopy has not shown to improve clinical outcome for trochanter bursa injections.

Although the use of fluoroscopy has not shown positive benefit, other modes of imaging, such as ultrasound have not been studied and may be more useful. Fluoroscopy allows for bony-landmark based injections. Ultrasound allows for direct visualization of the soft tissue structures such as the bursa and has gained significant support for use in musculoskeletal injections. This prospective blinded study's aim is to evaluate, if any, the benefit of an ultrasound guided injection and whether ultrasound should be routinely used during trochanter bursa injections.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

West Virginia University Hospitals

Morgantown, West Virginia, 26505, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of trochanteric bursitis
  • 18 years of age or older when written informed consent is obtained
  • Signed Institutional Review Board (IRB) approved informed consent form

Exclusion criteria

  • Allergy to triamcinolone or bupivicaine
  • Coagulopathy
  • Active Infection
  • Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments

Treatment and study plan

Trochanter bursa injections

Procedure

Ultrasound

Device

Primary outcomes

  1. Pain Intensity Measured on Visual Analog Scale (VAS)

    Time frame: 3 month

Secondary outcomes

  1. Disability Measured on Becks Disability Scale

    Time frame: Baseline, 2 weeks, 3 month

  2. Adverse Effects

    Time frame: 2 weeks, 3 month

  3. Pain Improvement

    Time frame: 2 weeks, 3 months

    Percent improvement

Sponsors and collaborators

Lead sponsor

West Virginia University

Other

Registry information

Official study title

Prospective, Randomized Trial of Ultrasound Guided and Blind Corticosteroid Injection for Trochanteric Bursitis

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Aug 20, 2014
Registry last updated
Oct 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.